The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes
Open accessAbstract
OBJECTIVE—To assess the efficacy of 1-h plasma glucose concentration and the metabolic syndrome in predicting future risk of type 2 diabetes. RESEARCH DESIGN AND METHODS—A total of 1,611 subjects from the San Antonio Heart Study, who were free of type 2 diabetes at baseline; who had plasma glucose and insulin concentrations measured at time 0, 30, 60, and 120 min during the oral glucose tolerance test (OGTT); and who had their diabetes status determined with an OGTT after 7–8 years of follow-up, were evaluated. Two models, based on glucose tolerance status, 1-h plasma glucose concentration, and presence of the metabolic syndrome, were tested in predicting the risk for type 2 diabetes at 7–8 years of follow-up. RESULTS—A cutoff point of 155 mg/dl for the 1-h plasma glucose concentration during the OGTT was used to stratify subjects in each glucose tolerance group into low, intermediate, and high risk for future type 2 diabetes. A model based upon 1-h plasma glucose concentration, Adult Treatment Panel (ATP) III criteria for the metabolic syndrome, and fasting plasma glucose, independent of 2-h plasma glucose, performed equally well in stratifying nondiabetic subjects into low, intermediate, and high risk for future type 2 diabetes and identified a group of normal glucose-tolerant subjects who were at very high risk for future type 2 diabetes. CONCLUSIONS—The plasma glucose concentration at 1 h during the OGTT is a strong predictor of future risk for type 2 diabetes. A plasma glucose cutoff point of 155 mg/dl and the ATP III criteria for the metabolic syndrome can be used to stratify nondiabetic subjects into three risk groups: low, intermediate, and high risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Self-citationImpaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Self-citationWriting committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108
Diabetes Mellitus: Report of a WHO Study Group.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-597_2 · Cited by 1,022
The Metabolic Syndrome as Predictor of Type 2 Diabetes
Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P., & Haffner, S. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3153 · Cited by 803
Abdul-Ghani, M. A., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2179 · Cited by 744
Self-citationWannamethee, S. G., Shaper, A. G., Lennon, L., & Morris, R. W. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2644 · Cited by 672
Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test
Abdul-Ghani, M. A., Matsuda, M., Balas, B., & DeFronzo, R. A. (2007) · Diabetes Care · doi:10.2337/dc06-1519 · Cited by 555
Self-citationStern, M. P., Williams, K., & Haffner, S. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00006 · Cited by 510
Abdul-Ghani, M. A., Jenkinson, C. P., Richardson, D. K., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes · doi:10.2337/db05-1200 · Cited by 500
Self-citationIdentification of Individuals With Insulin Resistance Using Routine Clinical Measurements
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.333 · Cited by 384
Self-citationWhat is the best predictor of future type 2 diabetes
Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M. (2007) · Diabetes Care · doi:10.2337/dc06-1331 · Cited by 355
Self-citationSTERN, M. P., ROSENTHAL, M., HAFFNER, S. M., HAZUDA, H. P., & FRANCO, L. J. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113956 · Cited by 308
Burke, J. P., Williams, K., Gaskill, S. P., Hazuda, H. P., Haffner, S. M., & Stern, M. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.13.1450 · Cited by 294
Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M. P. (2006) · Diabetes Care · doi:10.2337/dc05-1711 · Cited by 128
Self-citationMcNeely, M. J., Boyko, E. J., Leonetti, D. L., Kahn, S. E., & Fujimoto, W. Y. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.758 · Cited by 105
Predicting the Development of Diabetes in Older Adults
Kanaya, A. M., Wassel-Fyr, C. L., de Rekeneire, N., Shorr, R. I., Schwartz, A. V., Goodpaster, B. H., Newman, A. B., Harris, T. B., & Barrett-Connor, E. L. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.404 · Cited by 94
Lack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey
D, M. P. S. M. (1989) · JAMA · doi:10.1001/jama.1989.03430030048032 · Cited by 92
Cited by
Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.10001 · Cited by 1,279
Gestational diabetes: the need for a common ground
Reece, E. A., Leguizamón, G., & Wiznitzer, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60515-8 · Cited by 589
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes
Buijsse, B., Simmons, R. K., Griffin, S. J., & Schulze, M. B. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq019 · Cited by 297
Preservation of β-Cell Function: The Key to Diabetes Prevention
DeFronzo, R. A., & Abdul-Ghani, M. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0246 · Cited by 247
Self-citationFiorentino, T. V., Marini, M. A., Andreozzi, F., Arturi, F., Succurro, E., Perticone, M., Sciacqua, A., Hribal, M. L., Perticone, F., & Sesti, G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2573 · Cited by 138
Metadata
- Authors
- Abdul-Ghani, M. A., Abdul-Ghani, T., Ali, N., & DeFronzo, R. A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-08-01
- Volume
- 31
- Issue
- 8
- Pages
- 1650-1655
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2126753402
- Cited by
- 302
- References
- 24
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.